Business Description
GB Sciences Inc
NAICS : 325411
SIC : 2834
ISIN : US3615441090
Description
GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a range of ailments. The company's intellectual property covers various medical conditions, from which five drug development programs are in the preclinical stage of drug development including its formulations for Parkinson's disease (PD), chronic pain, cytokine release syndrome, depression, and cardiovascular therapeutic programs.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -61.49 | |||||
| Debt-to-Equity | -0.32 | |||||
| Debt-to-EBITDA | -2.01 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 24.6 | |||||
| 3-Year EPS without NRI Growth Rate | 28.6 | |||||
| 3-Year FCF Growth Rate | 39.4 | |||||
| 3-Year Book Growth Rate | -37.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.96 | |||||
| 9-Day RSI | 27.53 | |||||
| 14-Day RSI | 28.26 | |||||
| 6-1 Month Momentum % | -99.15 | |||||
| 12-1 Month Momentum % | -98.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.02 | |||||
| Quick Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.67 | |||||
| EV-to-EBITDA | -1.67 | |||||
| EV-to-FCF | -3.25 | |||||
| Earnings Yield (Greenblatt) % | -59.88 | |||||
| FCF Yield % | -2378.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GBLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GB Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.002 | ||
| Beta | 0.72 | ||
| Volatility % | 148.24 | ||
| 14-Day RSI | 28.26 | ||
| 14-Day ATR ($) | 0.000272 | ||
| 20-Day SMA ($) | 0.000155 | ||
| 12-1 Month Momentum % | -98.22 | ||
| 52-Week Range ($) | 0.00001 - 0.0135 | ||
| Shares Outstanding (Mil) | 407.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GB Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GB Sciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
GB Sciences Inc Frequently Asked Questions
What is GB Sciences Inc(GBLX)'s stock price today?
The current price of GBLX is $0.00. The 52 week high of GBLX is $0.01 and 52 week low is $0.00.
When is next earnings date of GB Sciences Inc(GBLX)?
The next earnings date of GB Sciences Inc(GBLX) is .
Does GB Sciences Inc(GBLX) pay dividends? If so, how much?
GB Sciences Inc(GBLX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers